历期数据

Markdown

拟议消费品安全法规定的咨询及过渡时间表

据描述,中药产品自 2027 年初起适用另一套框架;咨询提案本身并非已颁布的法律。

初步值

Consultation 1–29 July 2026; HSA intends to move remaining CHP medicinal-product controls from the Medicines Act to the Health Products Act by end-2028 consultation window and proposed policy timeline

统计期间
HSA consultation notice dated 1 July 2026
适用人群
Complementary health products in the consulted scope, including health supplements, specified traditional medicines, homeopathic medicines, medicated oils, balms, plasters and topical antiseptics
分母口径
Proposed framework and consultation scope; not enacted obligations for every product or final implementation rules
地理范围
新加坡

记录详情

发布日期
2026-07-01
指标
proposed chp regulation 2026 consultation
来源版本
HSA proposed CHP regulatory framework consultation

日期表示本记录的统计期间与适用范围。核验日期并不代表规则目前已经生效。

资料来源

  1. https://www.hsa.gov.sg/announcements/consultation-proposed-regulation-complementary-health-products/ 访问日期

知识库资料截至 2026-11-22 · 知识库持续扩充中。发布数量表示现有内容,并不代表已覆盖新加坡的全部知识。 机器可读版本: JSON · sgobs.consumer.proposed-chp-regulation-2026.consultation